Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZENITH: Sotatercept in Pulmonary Arterial Hypertension
NCT04896008Phase 3Completed
- Start
- Dec 2021
- Primary completion
- Jul 2024
- Modality
- Fc-Fusion Proteins
- Countries
- 12
01
Overview
A Phase 3 trial of sotatercept in pulmonary arterial hypertension (PAH). Started Dec 2021; status: completed.
02
Drugs
sotatercept
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT04896008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04896008.